NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Cue Biopharma (CUE) Technical (Analysis) Reports Cue Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Cue Biopharma (CUE)

Technical Analysis Report for USA stock CUE Cue Biopharma. Dated: 20 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock CUE Cue Biopharma then click here. or read Experts views on Cue Biopharma or Forecast & share price targets of Cue Biopharma

Cue Biopharma Opened at 15.98 and Closed at: 17.04, which is 5.63% of previous session's close. It moved within a range of 15.93 and 17.93
The session was a Bullish session with an average volume of 169100, which is 21.29% of previous session's volumes.

• Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
• Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
• The stock has shown an up move, and its long term trend is also positive and in an uptrend.

Support for tomorrow is 16.49 and resistance for tomorrow is 18.49
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 16, 14.97 resistance for tomorrow's hourly charts is 18, 18.97

10 Day SMA for Cue Biopharma (CUE) is 20.38 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Cue Biopharma (CUE) is 23.85 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Cue Biopharma (CUE) is 26.96 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 28.13 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Cue Biopharma is 17.37 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Cue Biopharma is at 23.85 and 200 DMA is at 17.37, while 50 DMA and 100 DMA are at 26.96 and 28.13 respectively

Cue Biopharma (CUE) moving average of 20 SMA is at 23.85 and 20 EMA is at 22.64

Cue Biopharma (CUE) moving average of 50 SMA is at 26.96 and 50 EMA is at 25.6

Cue Biopharma (CUE) moving average of 100 SMA is at 28.13 and 100 EMA is at 24.79

Cue Biopharma (CUE) moving average of 200 SMA is at 17.37 and 200 EMA is at 19.79

Unitedhealth Group has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Unitedhealth Group, about 59.2% more returns!

Takeda Pharmaceutical has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Takeda Pharmaceutical, about 53.01% more returns!

Novo Nordisk has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Novo Nordisk, about 49.35% more returns!

Msa Safety has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Msa Safety, about 45.92% more returns!

Johnson Johnson has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Johnson Johnson, about 42.64% more returns!

Dentsply Sirona has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Dentsply Sirona, about 36.96% more returns!

Rhythm Pharmaceuticals has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Rhythm Pharmaceuticals, about 38.08% more returns!

Irhythm Technologies has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Irhythm Technologies, about 48.14% more returns!

Ionis Pharmaceuticals has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Ionis Pharmaceuticals, about 49.61% more returns!

Immucell Corporation has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Immucell Corporation, about 50.86% more returns!

Co Diagnostics has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Co Diagnostics, about 5.35% more returns!

Axogen Inc has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Axogen Inc, about 29.75% more returns!

Aurinia Pharmaceuticals has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Aurinia Pharmaceuticals, about 48.33% more returns!

Aquestive Therapeutics has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Aquestive Therapeutics, about 32.43% more returns!

Aptevo Therapeutics has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Aptevo Therapeutics, about 31.97% more returns!

Achieve Life has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Achieve Life, about 29.4% more returns!

Cue Biopharma Technical analysis of indicators

Price action analysis of Cue Biopharma (CUE) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Cue Biopharma stock for short term is SELL. Signal strength is Strong and stock is losing momentum.

MACD generated a SELL signal for Cue Biopharma in short term and the sell signal is strong.

Cue Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up

CCI has generated a buy signal for Cue Biopharma in short term but BUY signal is weak.

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in negative zone. This is the SELL zone

Stock of Cue Biopharma is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 21.14 and Cue Biopharma CUE stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Cue Biopharma CUE stock. Volume based technical analysis of Cue Biopharma CUE stock is negative.

Cue Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock CUE Cue Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And CUE Experts View which covers a lot of information including buying and selling signals

CUE future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Cue Biopharma or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet